Publications by authors named "Conny van Ravenswaaij-Arts"

KPTN-related disorder is an autosomal recessive disorder associated with germline variants in KPTN (previously known as kaptin), a component of the mTOR regulatory complex KICSTOR. To gain further insights into the pathogenesis of KPTN-related disorder, we analysed mouse knockout and human stem cell KPTN loss-of-function models. Kptn -/- mice display many of the key KPTN-related disorder phenotypes, including brain overgrowth, behavioural abnormalities, and cognitive deficits.

View Article and Find Full Text PDF

Phelan-McDermid syndrome (PMS) is a rare neurodevelopmental disorder characterised by hypotonia, speech problems, intellectual disability and mental health issues like regression, autism and mood disorders. In the development, implementation and dissemination of a new clinical guideline for a rare genetic disorder like PMS, the parental experienced perspective is essential. As information from literature is scarce and often conflicting the European Phelan-McDermid syndrome guideline consortium created a multi-lingual survey for parents of individuals with PMS to collect their lived experiences with care needs, genotypes, somatic issues, mental health issues and parental stress.

View Article and Find Full Text PDF

This paper focuses on genetic counselling in Phelan-McDermid syndrome (PMS), a rare neurodevelopmental disorder caused by a deletion 22q13.3 or a pathogenic variant in SHANK3. It is one of a series of papers written by the European PMS consortium as a consensus guideline.

View Article and Find Full Text PDF

Phelan-McDermid syndrome (PMS) is an infrequently described syndrome that presents with a disturbed development, neurological and psychiatric characteristics, and sometimes other comorbidities. As part of the development of European medical guidelines we studied the definition, phenotype, genotype-phenotype characteristics, and natural history of the syndrome. The number of confirmed diagnoses of PMS in different European countries was also assessed and it could be concluded that PMS is underdiagnosed.

View Article and Find Full Text PDF

Background: Terminal 6p deletions are rare, and information on their clinical consequences is scarce, which impedes optimal management and follow-up by clinicians. The parent-driven Chromosome 6 Project collaborates with families of affected children worldwide to better understand the clinical effects of chromosome 6 aberrations and to support clinical guidance. A microarray report is required for participation, and detailed phenotype information is collected directly from parents through a multilingual web-based questionnaire.

View Article and Find Full Text PDF

Background: Even with the introduction of new genetic techniques that enable accurate genomic characterization, knowledge about the phenotypic spectrum of rare chromosomal disorders is still limited, both in literature and existing databases. Yet this clinical information is of utmost importance for health professionals and the parents of children with rare diseases. Since existing databases are often hampered by the limited time and willingness of health professionals to input new data, we collected phenotype data directly from parents of children with a chromosome 6 disorder.

View Article and Find Full Text PDF

Background: Terminal 6q deletions are rare, and the number of well-defined published cases is limited. Since parents of children with these aberrations often search the internet and unite via international social media platforms, these dedicated platforms may hold valuable knowledge about additional cases. The Chromosome 6 Project is a collaboration between researchers and clinicians at the University Medical Center Groningen and members of a Chromosome 6 support group on Facebook.

View Article and Find Full Text PDF
Article Synopsis
  • SHANK3-related Phelan-McDermid syndrome (PMS) arises from the loss of part of chromosome 22, impacting the SHANK3 gene, leading to a range of symptoms like developmental delay, language issues, autism, and epilepsy.
  • Genetic variations, including different sizes of deletions, can affect how severely these symptoms manifest in patients, indicating that not all cases of PMS involve SHANK3 directly.
  • The review highlights 110 genes in the 22q13 region that may play a role in neurodevelopmental disorders, suggesting the need for future studies to better understand these connections and improve care for PMS patients.
View Article and Find Full Text PDF
Article Synopsis
  • Phelan-McDermid syndrome (PMS) is a rare genetic disorder characterized by developmental delays, hypotonia, and significant speech delays, with behavioral difficulties often reported but not well understood.
  • A study involving 33 children with PMS utilized direct neurodevelopmental assessments and parent questionnaires to evaluate developmental, adaptive, and social-emotional behaviors.
  • Results indicated variability in behavior and symptom severity, with many children showing traits associated with Autism Spectrum Disorder, highlighting the need to interpret behaviors within the context of cognitive and adaptive development.
View Article and Find Full Text PDF

Craniosynostosis, the premature fusion of the calvarial bones, has numerous etiologies. Among them, several involve mutations in genes related to the TGFb signaling pathway, a critical molecular mediator of human development. These TGFb pathway-associated craniosynostosis syndromes include Loeys-Dietz syndrome (LDS) and Shprintzen-Goldberg syndrome (SGS).

View Article and Find Full Text PDF

Phelan-McDermid syndrome (PMS) was initially called the 22q13 deletion syndrome based on its etiology as a deletion of the distal long arm of chromosome 22. These included terminal and interstitial deletions, as well as other structural rearrangements. Later, pathogenetic variants and deletions of the SHANK3 gene were found to result in a phenotype consistent with PMS.

View Article and Find Full Text PDF

Deletions that include the gene TAB2 and TAB2 loss-of-function variants have previously been associated with congenital heart defects and cardiomyopathy. However, other features, including short stature, facial dysmorphisms, connective tissue abnormalities and a variable degree of developmental delay, have only been mentioned occasionally in literature and thus far not linked to TAB2. In a large-scale, social media-based chromosome 6 study, we observed a shared phenotype in patients with a 6q25.

View Article and Find Full Text PDF

Diabetes mellitus (DM) in children is most often caused by impaired insulin secretion (type 1 DM). In some children, the underlying mechanism for DM is increased insulin resistance, which can have different underlying causes. While the majority of these children require insulin dosages less than 2.

View Article and Find Full Text PDF

CHARGE syndrome is an autosomal dominant malformation disorder caused by pathogenic variants in the chromatin remodeler CHD7. Affected are craniofacial structures, cranial nerves and multiple organ systems. Depending on the combination of malformations present, its distinction from other congenital disorders can be challenging.

View Article and Find Full Text PDF

Ephrin receptor and their ligands, the ephrins, are widely expressed in the developing brain. They are implicated in several developmental processes that are crucial for brain development. Deletions in genes encoding for members of the Eph/ephrin receptor family were reported in several neurodevelopmental disorders.

View Article and Find Full Text PDF

Genetic testing and counselling are increasingly important in epilepsy care, aiming at finding a diagnosis, understanding aetiology and improving treatment and outcome. The psychological impact of genetic counselling from patients' or parents' perspectives is, however, unknown. We studied the counselee-reported outcome of genetic counselling before and after genetic testing for epilepsy by evaluating empowerment - a key outcome goal of counselling reflecting cognitive, decisional and behavioural control, emotional regulation and hope - and anxiety.

View Article and Find Full Text PDF

Purpose: Despite a few recent reports of patients harboring truncating variants in NSD2, a gene considered critical for the Wolf-Hirschhorn syndrome (WHS) phenotype, the clinical spectrum associated with NSD2 pathogenic variants remains poorly understood.

Methods: We collected a comprehensive series of 18 unpublished patients carrying heterozygous missense, elongating, or truncating NSD2 variants; compared their clinical data to the typical WHS phenotype after pooling them with ten previously described patients; and assessed the underlying molecular mechanism by structural modeling and measuring methylation activity in vitro.

Results: The core NSD2-associated phenotype includes mostly mild developmental delay, prenatal-onset growth retardation, low body mass index, and characteristic facial features distinct from WHS.

View Article and Find Full Text PDF
Article Synopsis
  • VPS41 is part of the HOPS complex important for lysosomal fusion and regulated secretion, and mutations in VPS41 were found in three patients with neurodegeneration characterized by ataxia and dystonia.
  • Mutations resulted in dysfunctional HOPS complex formation, leading to delayed lysosomal delivery of cellular materials and altered cellular signaling pathways, particularly affecting mTORC1 and autophagy responses.
  • In a C. elegans model of Parkinson's disease, VPS41 mutations undermined its neuroprotective role against toxic protein aggregates, suggesting the variants contribute to a neurodegenerative disease by disrupting critical cellular functions.
View Article and Find Full Text PDF

Purpose: Postsynaptic density protein-95 (PSD-95), encoded by DLG4, regulates excitatory synaptic function in the brain. Here we present the clinical and genetic features of 53 patients (42 previously unpublished) with DLG4 variants.

Methods: The clinical and genetic information were collected through GeneMatcher collaboration.

View Article and Find Full Text PDF

We present key points from the updated Dutch-Flemish guideline on comprehensive diagnostics in disorders/differences of sex development (DSD) that have not been widely addressed in the current (inter)national literature. These points are of interest to physicians working in DSD (expert) centres and to professionals who come across persons with a DSD but have no (or limited) experience in this area. The Dutch-Flemish guideline is based on internationally accepted principles.

View Article and Find Full Text PDF

Aneuploidy mosaicism involving two complementary different autosomal trisomy cell lines is extremely rare. Although a mosaic double trisomy 8/trisomy 21 has been described in literature, this is the first report of Warkany (+8)-Down (+21) syndrome due to two complementary mosaic trisomy cell lines. The phenotype of the male patient with Warkany-Down syndrome includes upslanting palpebral fissures, hypertelorism, small low-set ears with unilateral aural stenosis, large and broad hands and feet with deep palmar and plantar creases, bilateral cryptorchidism, generalized mild hypotonia and transient neonatal thrombocytopenia.

View Article and Find Full Text PDF
Article Synopsis
  • - Sirenomelia is a rare and severe birth defect with unknown causes, characterized by fused legs and serious internal organ issues.
  • - Researchers studied nine families with this condition using advanced exome sequencing, identifying specific genetic variants in the CDX2 gene linked to two family cases, following an autosomal dominant inheritance pattern.
  • - The study suggests a genetic role in sirenomelia, revealing additional potential gene variants and emphasizing the importance of the Cdx and Wnt signaling pathways in its development.
View Article and Find Full Text PDF